Horster Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 26-07-2024
- Paid Up Capital ₹ 4.19 M
as on 26-07-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.16 Cr
as on 26-07-2024
- Satisfied Charges ₹ 11.85 Cr
as on 26-07-2024
- Revenue -52.14%
(FY 2023)
- Profit -99.83%
(FY 2023)
- Ebitda -84.74%
(FY 2023)
- Net Worth 301.05%
(FY 2023)
- Total Assets 117.91%
(FY 2023)
About Horster Life Science
The Corporate was formerly known as Clairchem India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.19 M.
The company currently has active open charges totaling ₹10.16 Cr. The company has closed loans amounting to ₹11.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mehul Jhaveri, Manish Tilala, and Mansukhlal Dhameliya serve as directors at the Company.
- CIN/LLPIN
U24100GJ2013PTC077207
- Company No.
077207
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Horster Life Science Private Limited offer?
Horster Life Science Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Horster Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Jhaveri  | Director | 14-Oct-2013 | Current |
| Manish Tilala | Director | 14-Oct-2013 | Current |
| Mansukhlal Dhameliya | Director | 16-Jun-2023 | Current |
Financial Performance of Horster Life Science.
Horster Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.14% decrease. The company also saw a substantial fall in profitability, with a 99.83% decrease in profit. The company's net worth Soared by an impressive increase of 301.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horster Life Science?
In 2022, Horster Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Horster Biotek Private LimitedActive 14 years 15 daysMehul Jhaveri and Manish Tilala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 10 Mar 2023 | ₹3.22 Cr | Open |
Axis Bank Limited Creation Date: 01 Sep 2022 | ₹6.94 Cr | Open |
Others Creation Date: 21 Jun 2022 | ₹4.95 Cr | Satisfied |
How Many Employees Work at Horster Life Science?
Unlock and access historical data on people associated with Horster Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horster Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horster Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
